Recruiting
Phase 2

Vaccine with CLL

Sponsor:

Seema Bhat

Code:

NCT05417165

Conditions

Chronic Lymphocytic Leukemia

Small Lymphocytic Lymphoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Pneumococcal 20-valent Conjugate Vaccine

Pneumococcal Polyvalent Vaccine

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-01. This information was provided to ClinicalTrials.gov by Seema Bhat on 2024-12-31.